Table 2.
Percentages of self-reported symptoms in the acute phase as a function of severity of respiratory symptoms
| Total sample N = 121 |
Mild subgroup n = 49 |
Moderate subgroup n = 48 |
Severe subgroup n = 24 |
|
|---|---|---|---|---|
| Runny nose | 25.47% | 32.65% | 18.75% | 25.00% |
| Sore throat | 16.51% | 22.45% | 14.58% | 12.50% |
| Muscle pain | 49.50% | 71.43% | 39.58% | 37.50% |
| Loss of sense of smell | 39.20% | 55.10% | 50.00% | 12.50% |
| Taste disorder | 37.85% | 48.98% | 47.92% | 16.67% |
| Dry cough | 54.49% | 53.06% | 56.25% | 54.17% |
| Productive cough | 6.16% | 12.24% | 6.25% | 0.00% |
| Fever | 0.00% | 0.00% | 0.00% | 0.00% |
| Digestive symptoms | 67.64% | 59.18% | 72.92% | 70.83% |
| Fatigue | 33.11% | 32.65% | 45.83% | 20.83% |
| Difficulty breathing | 76.50% | 83.67% | 83.33% | 62.50% |
| Chest pain | 45.59% | 34.69% | 52.08% | 50.00% |
| Headache | 23.44% | 24.49% | 25.00% | 20.83% |
| Somnolence | 26.12% | 38.78% | 27.08% | 12.50% |
| Nonrestorative sleep | 55.73% | 75.51% | 54.17% | 37.50% |
| Insomnia | 32.41% | 32.65% | 35.42% | 29.17% |
| Waking up feeling choked or suffocated | 17.98% | 10.20% | 22.92% | 20.83% |
| Snoring | 12.46% | 6.12% | 18.75% | 12.50% |
| Interruption of breathing during sleep | 0.69% | 0.00% | 2.08% | 0.00% |
| Other | 5.56% | 0.00% | 8.33% | 8.33% |
| None | 19.30% | 20.41% | 29.17% | 8.33% |
Note. Mild: patients not hospitalized for SARS-CoV-2 infection; Moderate: patients hospitalized without mechanical ventilation for SARS-CoV-2 infection; and Severe: patients hospitalized in intensive care with mechanical ventilation for SARS-CoV-2 infection.